NEW YORK (GenomeWeb) – Goldman Sachs released its yearly outlook for the omics sector today, lowering its outlook of the life science research tools industry to Neutral from Attractive, and raising its rating on labs to Attractive. The investment bank also stayed Neutral on the diagnostics sector.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers describe a way to share data while keeping it secure, Agence France Presse reports.

In Science this week: genetic mutations typically associated with esophageal cancer are common in older, healthy individuals, and more.

India's Council of Scientific and Industrial Research has a new director-general, according to ScienceInsider.

A new study links more than a hundred genes to autism spectrum disorder, Discover's D-brief blog reports.